Craif Raises $33M to Advance US Cancer Testing Platform
· ventureburn.com
Craif Raises $33M to advance urine-based cancer testing and expand US research for pancreatic cancer diagnosis and detection.
Craif will expand US research and prepare its non-invasive test for reimbursement-driven commercialisation.
Craif Raises Series D for Cancer Detection
Craif h...